Pneumatic dilation versus intrasphincteric botulinum toxin injection in the treatment of achalasia cardia in India: An economic analysis

Indian Journal of Gastroenterology

Volumn 21, Issue 5, 2002, Pages 193-196

  Ghoshal, U C ^a   Aggarwal, R ^a   Kumar, S ^a   Naik, S R ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Cost analysis; Decision analysis

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; BALLOON; COMPUTER PROGRAM; COST BENEFIT ANALYSIS; CUFF; DECISION THEORY; DEVICE; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; DRUG SAFETY; ESOPHAGUS ACHALASIA; HEALTH CARE COST; HUMAN; INDIA; MONEY; PROBABILITY; SENSITIVITY ANALYSIS; TREATMENT FAILURE;

AGED; BOTULINUM TOXIN TYPE A; COST-BENEFIT ANALYSIS; DECISION TREES; DILATATION; ESOPHAGEAL ACHALASIA; ESOPHAGOGASTRIC JUNCTION; HUMANS; INDIA; INJECTIONS; MIDDLE AGED; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0036745992     PISSN: 02548860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Wong RKH, Maydonovitch CL. Achalasia. In: Castell DO, Ed. The Esophagus. New York: Little Brown. 1995: p. 219-47.
2. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Botulinum toxin for the treatment of achalasia. N Engl J Med 1995;322:774-8.
3. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin in achalasia: long-term outcome and predictors of response. Gastroenterology 1996;110:1410-5.
4. Vaezi MF, Richter JE, Wilcox CM, Schroeder PL, Birgisson S, Slaughter RL, et al. Botulinum toxin versus pneumatic dilatation in treatment of achalasia: a randomised trial. Gut 1999;44:231-9.
5. Annese V, Basciani M, Perri F, Lombardi G, Fruscianti V, Simone P, et al. Controlled trial of botulinum toxin injection versus placebo and pneumatic dilatation in achalasia. Gastroenterology 1996;111:1418-24.
6. Annese V, Bassotti G, Coccia G, Dinelli M, O'Onofrio V, Gatto G, et al. The GISMAD achalasia study group. A multicentric randomised study of intrasphincteric botulinum toxin in patients with oesophageal achalasia. Gut 2000;46:597-600.
7. Ghoshal UC, Chowdhury S, Pal BB, Dhar K, Ray G, Banerjee PK. Randomized controlled trial of intrasphincteric botulinum toxin injection versus balloon dilatation in treatment of achalasia cardia. Dis Esophagus 2001;14:227-31.
8. Schiano TD, Parkman HP, Miller LS, Dabezies MA, Cohen S, Fisher RS. Use of botulinum toxin in the treatment of achalasia. Dig Dis 1998;16:14-22.
9. Prakash C, Freedland KE, Chan MF, Clouse RE. Botulinum toxin injection for achalasia symptoms can approximate the short-term efficacy of a single pneumatic dilation: a survival analysis approach. Am J Gastroenterol 1999;94:328-33.
10. Muehldorfer SM, Schneider TH, Hochberger J, Martus P, Hahn EG, Ell C. Esophageal achalasia: intrasphincteric injection of botulinum toxin A versus balloon dilation. Endoscopy 1999;31:517-21.
11. Bhatnagar M, Nanivadekar SA, Sawant P, Rathi PM. Achalasia cardia dilatation using polyethylene balloon (Rigiflex) dilator. Indian J Gastroenterol 1996;15:49-51.
12. Rajput S, Nandawani SK, Phadke AY, Bhandarkar PV, Abraham P, Tilve GH. Predictors of response of pneumatic dilatation in achalasia cardia. Indian J Gastroenterol 2000;19:126-9.
13. Shahi HM, Aggarwal R, Misra A, Agarwal D, Naik SR. Relationship of manometric findings to symptomatic response after pneumatic dilation in achalasia cardia. Indian J Gastroenterol 1998;17:19-21.
14. Tandon RK, Arora A, Mehta S. Pneumatic dilatation is a satisfactory first-line treatment for achalasia. Indian J Gastroenterol 1991;10:4-6.
15. Shaffer HA, Valenzuela G, Mittal RK. Esophageal perforation: a reassessment of the criteria for choosing medical or surgical therapy. Arch Intern Med 1992;152:757-61.
16. Sood A, Singh G, Kharay AS. Role of botulinum toxin in treatment of achalasia cardia. Indian J Gastroenterol 1996;15:97-8.
17. Kolbasnik J, Waterfall WE, Fachie B, Chen Y, Tougas G. Long-term efficacy of botulinum toxin in classical achalasia: a prospective study. Am J Gastroenterol 1999;94:3434-9.
18. Jones WG, Ginsberg RJ. Esophageal perforation: a continuing challenge. Ann Thorac Surg 1992;53:534-43.
19. Patti MG, Feo CV, Arcerito M, De Pinto M, Tamburini A, Diener U, et al. Effect of previous treatment on result of laparoscopic Heller's myotomy for achalasia cardia. Dig Dis Sci 1999;44:2270-6.
20. Horgan S, Hudda K, Eubanks T, McAllister J, Pellegrini CA. Does botulinum toxin injection make esophagomyotomy a more difficult operation? Surg Endosc 1999;13:576-9.
21. Annese V, Bassotti G, Coccia G, D'Onofrio V, Gatto G, Repici A, et al. Comparison of two different formulations of botulinum toxin A for the treatment of esophageal achalasia: The GISMAD Achalasia Study Group. Aliment Pharmacol Ther 1999;13:1347-50.
22. Panaccione R, Gregor JC, Reynolds RPE, Preiksaitis HG. Intrasphincteric botulinum toxin versus pneumatic dilatation for achalasia: a cost minimization analysis. Gastrointest Endosc 1999;50:492-8.
23. Dhir VK, Abraham P. The science, law and ethics of fashioning and refashioning endoscopic accessories. Indian J Gastroenterol 2000;19:107-8.
24. Birgisson S, Richter JE. Achalasia: What's new in diagnosis and treatment? In: Achem SR, Quigley EMM, Rao SSC, Snape WJ. Eds. Development and Controversies in Gastrointestinal Motility. New York: S Kargar. 1997: p. 2-27.
25. Ellis FH. Esophagectomy for achalasia: who, when and how much? Ann Thor Surg 1989;47:334-5.